Showing results (971-980 of 1,024) with videos related to
Sort By:
Pageof 103
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 22, 2023
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)Susanna Naggie, Aaron Milstone, Mario Castro, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancerE E W Cohen, L F Licitra, B Burtness, et al.Science Translational Medicine|December 8, 2017
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infectionMichael C Sneller, J Shawn Justement, Kathleen R Gittens, et al.Cancer Research|March 11, 2010
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancersS Michael Rothenberg, Gayatry Mohapatra, Miguel N Rivera, et al.British Journal of Anaesthesia|August 11, 2023
An anchor-tether 'hindered' HCN1 inhibitor is antihyperalgesic in a rat spared nerve injury neuropathic pain modelGareth R Tibbs, Rajendra Uprety, J David Warren, et al.Nature Communications|July 25, 2022
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCCRobert Saddawi-Konefka, Aoife O'Farrell, Farhoud Faraji, et al.Journal of Virology|August 23, 2019
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine TrialShuying S Li, Peter B Gilbert, Lindsay N Carpp, et al.JAMA Oncology|June 23, 2018
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical TrialRobert L Ferris, Nabil F Saba, Barbara J Gitlitz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
INDUCE-3: A randomized Phase II/III study of first-line feladilimab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinomaDanny Rischin, Aaron R Hansen, Ezra E W Cohen, et al.Nature|December 14, 2017
Origin and differentiation of human memory CD8 T cells after vaccinationRama S Akondy, Mark Fitch, Srilatha Edupuganti, et al.Pageof 103